# Trio Pharmaceuticals, Inc. — Form D

Trio Pharmaceuticals, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-10. The offering totals $1.7M, of which $1.5M was reported sold. Industry: Other.

## Offering

- Filed: 2022-11-10
- Form: D
- Accession: 0001953931-22-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $1.7M
- Amount sold: $1.5M
- Remaining: $164K
- Investors: 6
- Date of first sale: 2022-11-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-464453

## Issuer

- Name: Trio Pharmaceuticals, Inc.
- CIK: 0001953931
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 11956 Bernardo Plaza Drive, Suite 160, San Diego, CA, 92128
- Phone: (619) 786-3495

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Reiner Laus | Director | San Diego, CA |
| Reiner Laus | Executive Officer | San Diego, CA |
| Shivarupam Bhowmik | Director | San Diego, CA |
| Shivarupam Bhowmik | Executive Officer | San Diego, CA |
| Jeffrey Friedman | Director | Grass Lake, MI |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-12-13](https://search.stillhousedata.com/formd/0001953931-22-000002) | D/A | $2.4M | $1.9M |

## More

- [CIK 1953931 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1953931&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001953931-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.